Insulin and Glucagon Secretory Responses to Arginine, Glue agon, and Theophylline During Perifusion of Human Fetal Islet-Like Cell Clusters*
- 1 October 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 67 (4), 734-740
- https://doi.org/10.1210/jcem-67-4-734
Abstract
The secretory responsiveness of human fetal pancreatic endocrine cells was studied by perifusion of cultured islet-like clusters (ICC). ICC were obtained from 7 fetuses at 13-15 weeks gestation and 21 fetuses at 17-22 weeks gestation. The ICC were challenged with glucose (20 mmol/L), arginine (10 mmol/L), glucagon (1.4 .mu.mol/L), and theophylline (10 mmol/L) combined with zero, low (2 mmol/L), or high (20 mmol/L) glucose. At 13-15 weeks, glucose and arginine enhanced insulin release in some experiments, whereas glucagon and theophylline were always potent stimuli (mean response, 4-fold regardless of the glucose concentration). At 17-22 weeks, both glucose alone (20 mmol/L) and arginine (10 mmol/L, with 2 mmol/L glucose) induced a small (1.4- to 1.5-fold) increase in insulin release. When arginine was combined with 20 mmol/L glucose, the response was potentiated to become a 2.3-fold increase. In contrast, glucagon was equally effective in 2 and 20 mmol/L glucose (2.9- and 2.6-fold responses, respectively) and produced a half-maximal response even in the absence of glucose. In this age range the most potent stimulus for insulin release was clearly theophylline. The effect of theophylline was also remarkably independent of the glucose concentration of the perifusate (5.6-, 8.1-, and 8.6-fold responses at 0, 2, and 20 mmol/L glucose, respectively). Glucagon release from the ICC of the 17- to 22-week-old fetuses was low (mean basal glucagon release, 2.9; insulin, 24.8 fmol/100 ICC/min). Glucagon release was not affected by 20 mmol/L glucose, but was stimulated by arginine and theophylline. These findings suggest that in the fetal pancreas, in contrast to the adult organ, insulin release results from elevated of intracellular cAMP concentrations (by glucagon or theophylline) relatively independent of the exogenous glucose concentration. Therefore, glucagon may have an important role in regulating insulin release during the early development of human fetal B-cells.This publication has 11 references indexed in Scilit:
- Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic isletlike cell clustersDiabetes, 1988
- Tissue culture of human fetal pancreas. Effects of human serum on development and endocrine function of isletlike cell clustersDiabetes, 1987
- The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse isletsDiabetologia, 1987
- Fuel-stimulated insulin secretion by clonal hamster beta-cell line HIT T-15Diabetes, 1987
- Regulation of Adenosine 3′,5′-Monophosphate Levels in the Pancreatic B Cell*Endocrinology, 1985
- Interplay of Nutrients and Hormones in the Regulation of Insulin Release*Endocrinology, 1985
- Human fetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancyAmerican Journal of Obstetrics and Gynecology, 1984
- Time-dependent inhibition of insulin release: glucose-arginine interactions in the perfused rat pancreasDiabetologia, 1984
- Insulin secretion by fetal human pancreas in organ cultureDiabetologia, 1982
- The Adenylate cyclase-cyclic AMP system in islets of langerhans and its role in the control of insulin releaseDiabetologia, 1979